Skip to main content

Articles

Page 2 of 13

  1. In low- and middle-income countries, too, public–private partnerships in health insurance schemes are crucial for improving access to health services. Problems in the public supply chain of medicines often lea...

    Authors: Angel Dillip, Albino Kalolo, Iddy Mayumana, Melina Rutishauser, Vendelin T. Simon and Brigit Obrist
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:106
    Content type: Research Published on:

  2. Breast cancer (BC) is the most common cancer globally among women, with 2,261,419 new cases in 2020; systemic treatment may be neo-adjuvant, adjuvant, or both. BC subtype guides the standard systemic therapy a...

    Authors: Ghader Mohammadnezhad, Melika Sattarpour and Najmeh Moradi
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:105
    Content type: Review Published on:

  3. The Drug Regulatory Authority of Pakistan (DRAP) in response to the public outcry on increasing medicines prices in the country issued notifications to direct healthcare professionals to prescribe medicines wi...

    Authors: Hamid A. Merchant, Zaheer-Ud-Din Babar and Izhar M. Hussain
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:104
    Content type: Commentary Published on:

  4. Patient medication counselling (PMC) is a pharmaceutical care service targeted at optimizing patient drug use, safety and improving treatment outcomes. This study assessed the content and quality of PMC from t...

    Authors: Segun Johnson Showande and Monioluwa Wonuola Laniyan
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:103
    Content type: Research Published on:

  5. The COVID-19 pandemic has harshly burdened the healthcare systems. Health care workers (HCWs) are at substantial risk of infection and confronted several stressors as well leading them to experience burnout. T...

    Authors: Dalal Youssef, Edmond Abboud, Linda Abou-Abbas, Hamad Hassan and Janet Youssef
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:102
    Content type: Research Published on:

  6. General practices in primary care across England are increasingly employing clinical pharmacists to help tackle the workforce crisis and alleviate pressure. Clinical pharmacists can provide administrative and ...

    Authors: Elisha Chopra, Tanvi Choudhary, Ankie Hazen, Sunil Shrestha, Inderpal Dehele and Vibhu Paudyal
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:101
    Content type: Research Published on:

  7. Pharmacist-led medication reviews are considered a valuable measure to address risks of polypharmacy. The software Medinspector® is used in community pharmacies to assist the performance of this complex service b...

    Authors: Stefan Maierhöfer, Isabell Waltering, Mareike Jacobs, Gudrun Würthwein, Meike Appelrath, Susanne Koling and Georg Hempel
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:100
    Content type: Study Protocol Published on:

  8. There is limited data to describe the point-prevalence of healthcare-associated infections (HAIs) among patients at a regional level in Africa. This study estimated the pooled prevalence of HAIs and described ...

    Authors: Usman Abubakar, Omalhassan Amir and Jesús Rodríguez-Baño
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:99
    Content type: Review Published on:

  9. Atrial fibrillation (AF) affects up to 2% of the UK population. AF is a potentially long-term condition that needs management, and as such primary care pharmacists may have a substantial role in supporting the...

    Authors: Shahd Al-Arkee, Julie Mason, Antje Lindenmeyer and Zahraa Jalal
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:98
    Content type: Research Published on:

  10. Globally, cardiovascular disease (CVD) is a leading cause of death and disproportionately affects low- and middle-income countries (LMICs). The WHO Model List of Essential Medicines (WHO EML) is a tool for imp...

    Authors: Ian Naicker, Fatima Suleman and Velisha Ann Perumal-Pillay
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:97
    Content type: Research Published on:

  11. Appropriate distribution of health care resources is required to adjust regional disparities in the quality of health care. Besides, the number of community pharmacists in Japan has increased recently, but the...

    Authors: Kazuhiro Iguchi, Midori Ueyama, Hiroto Nishio, Hirofumi Tamaki, Arihiro Osanai, Yoko Ino, Kazuya Nonomura, Megumi Horibe, Toshiyuki Matsunaga and Mitsuhiro Nakamura
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:96
    Content type: Research Published on:

  12. Effective vaccine management is essential to maintain the quality of vaccines, minimise wastages, and prevent missed opportunities for vaccination at service delivery points.

    Authors: Bonaventura Nestory, Mackfallen Anasel, Jean Baptiste Nyandwi and Domina Asingizwe
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:95
    Content type: Research Published on:

  13. Globally accepted roles of pharmacists are described in the Good Pharmacy Practice (GPP) standards, published by the World Health Organization (WHO) and the International Pharmaceutical Federation (FIP) in 201...

    Authors: Zuzana Kusynová, Hendrika A. van den Ham, Hubert G. M. Leufkens and Aukje K. Mantel-Teeuwisse
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:94
    Content type: Research Published on:

  14. Lebanon has been recognized as a center for high-quality healthcare services in the Middle East because of its prestigious facilities certified by international bodies, competent health workers, and credible p...

    Authors: Elsa Nassar, Sibelle Kassouf, Aline Hajj, Hala Sacre, Marwan Akel, Rony M. Zeenny, Chadia Haddad and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:93
    Content type: Research Published on:

  15. Despite its importance in ensuring sustainable healthcare, there are huge challenges with pharmaceutical research and development (R&D) especially for developing countries mainly due to the high investment cos...

    Authors: Muluken Nigatu Selam, Samuel Abera, Helen Geremew and Eskinder Eshetu Ali
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:92
    Content type: Research Published on:

  16. Family planning involves the use of traditional or modern methods to prevent maternal and infant mortality associated with unintended pregnancies and negative economic outcomes. In sub-Saharan Africa, the unme...

    Authors: Fredrick Githinji, Shital M. Maru, Peter N. Karimi, Eugene Rutungwa and Egide Kayitare
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:91
    Content type: Research Published on:

  17. Access to quality medicines is a global initiative to ensure universal health coverage. However, the limited capacity of National Medicines Regulatory Authorities (NMRAs) to prevent and detect the supply of po...

    Authors: Jean Baptiste B. Shabani, Egide Kayitare, Eric Nyirimigabo, Vedaste Habyalimana, Marilyn M. Murindahabi, Lazare Ntirenganya, Clarisse Irasabwa, Eugene Rutungwa, Jose Edouard Munyangaju and Innocent Hahirwa
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:90
    Content type: Research Published on:

  18. Yemen's health system has severely deteriorated due to the ongoing civil war accompanied by the COVID-19 pandemic which coincided with other outbreaks of endemic infections. Many health institutions closed due...

    Authors: Ebtesam A. Saleh, Randa N. Haddadin, Bassam Saleh and Eman Elayeh
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:89
    Content type: Research Published on:

  19. High-risk medications use at home entails an increased risk of significant harm to the patient. While interventions and strategies to improve medications care have been implemented in hospitals, it remains unc...

    Authors: Irina Dumitrescu, Minne Casteels, Kristel De Vliegher, Laura Mortelmans and Tinne Dilles
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:88
    Content type: Research Published on:

  20. Currently in Greece, no formal organisation offers post-academic education to pharmacists. To improve the clinical practice of pharmacists, there is a need for training that will educate them on how to approac...

    Authors: Aliki Peletidi and Reem Kayyali
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:87
    Content type: Research Published on:

  21. Regular measurement of the availability and use of key medicines for non-communicable diseases allows the tracking of progress to achieve equitable access to medicines. Using a country-level public sector moni...

    Authors: Janeth Tenorio-Mucha, María Lazo-Porras, Jessica Zafra, Margaret Ewen and David Beran
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:86
    Content type: Research Published on:

  22. Efforts in the pharmaceutical market have been aimed at ensuring that the benefits obtained from the introduction of new therapies justify the associated costs. In recent years, drug payment models in healthca...

    Authors: Jose Luis Poveda, Rosa Bretón-Romero, Carlos Del Rio-Bermudez, Miren Taberna and Ignacio H. Medrano
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:85
    Content type: Commentary Published on:

  23. An irrational antibiotic use is a common problem in developing countries like Ethiopia, which makes empiric antibiotics use difficult. It is considered to be the greatest health problem in our time and future ...

    Authors: Mesay Dechasa, Legese Chelkeba, Amente Jorise, Birbirsa Sefera and Tsegaye Melaku
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:84
    Content type: Research Published on:

  24. Pharmaceutical research can be structured into clear national strategies that optimize patient health and foster innovation. The objectives of this document are to assess the need for a national pharmaceutical...

    Authors: Marwan Akel, Aline Hajj, Hala Sacre, Rony M. Zeenny, Chadia Haddad and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:83
    Content type: Commentary Published on:

  25. Antimicrobial resistance (AMR) is a global public health issue. Physicians should play a key role to fight AMR, and medical education is a fundamental issue to combat it. Understanding the knowledge, attitudes...

    Authors: Ramin Sami, Raheleh Sadegh, Fataneh Fani, Vajihe Atashi and Hamid Solgi
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:82
    Content type: Research Published on:

  26. Vaccination is an effective public health intervention in reducing morbidity and mortality of infectious diseases. Compared to other countries where community pharmacists (CPs) administer vaccines, CPs in Mala...

    Authors: Wei Chern Ang, Mohamad Syafuan Fadzil, Fatin Najihah Ishak, Nassrah Norissya Adenan and Mohamad Haniki Nik Mohamed
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:81
    Content type: Research Published on:

  27. Allergic rhinitis has been identified as a major respiratory disease that places a significant burden on patients and the healthcare system. Nevertheless, the management of allergic rhinitis is challenging for...

    Authors: Chii-Chii Chew, Chee-Tao Chang, Xin-Jie Lim, Wai-Yin Yong, Doris George, Pathma Letchumanan, Philip Rajan and Chee Ping Chong
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:80
    Content type: Commentary Published on:

  28. The generalized use of antibiotics has led to the emergence of bacteria which are resistant to antimicrobial agents. This stems in part from the patient's tendencies to seek antibiotics for diseases when not n...

    Authors: Atsushi Ito, Yuichi Watanabe and Takashi Okumura
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:79
    Content type: Research Published on:

  29. Branded drug samples are one of the most important promotional tools that pharmaceutical manufactures employ. Pharmaceutical sales representatives (“drug reps”) use samples to gain access to physicians and oth...

    Authors: Emily Couvillon Alagha and Adriane Fugh-Berman
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:78
    Content type: Commentary Published on:

  30. Psychological morbidity has been documented in medical and pharmaceutical undergraduate students in different countries around the world. In this study, we examined the impact of coronavirus disease 2019 (COVI...

    Authors: Asmaa S. Mohamed, Ahmed A. Abdelrahman, Hosam M. Ahmad, Omar R. Abdel Aziz, Yasmeen S. Mesameh and Soad A. Mohamad
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:77
    Content type: Research Published on:

  32. Evidence has shown that there is a significant problem with medication safety when patients are transferred between settings. The role of community pharmacists and hospital pharmacists in facilitating transiti...

    Authors: Faiza Yahya, Hamde Nazar and Muhammad Abdul Hadi
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:75
    Content type: Study Protocol Published on:

  33. Reforms to models of health and care regulation internationally have adapted to address the challenges associated with regulating healthcare professionals. Pharmacists in Ireland entered a new era of regulatio...

    Authors: Matthew Lynch, Naonori Kodate, Conor Hickey and Aisling C. O’Leary
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:74
    Content type: Research Published on:

  34. The burden of Human Papilloma Virus (HPV)-associated cancer remains high in developing nations.

    Authors: Mathumalar Loganathan Fahrni, Muhamad Zabidi Azni, Nurhani Syafiqah Mohd Rusdi, Chee-Yan Choo, Khairil Anuar Md Isa and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:73
    Content type: Research Published on:

  35. With countries moving towards reaching the UNAIDS 90-90-90 goal to achieve HIV epidemic control, there are going to be an unprecedented number of persons who will need to be tested, treated, and regularly moni...

    Authors: Sowedi Muyingo, David Etoori, Paul Lotay, Samuel Malamba, James Olweny, King Keesler, Steven Wiersma, Pito Jjemba and Rashid Settaala
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:72
    Content type: Research Published on:

  36. Despite appropriate treatment of epilepsy, the treatment outcome is poor in developing country. Therefore, the study was aimed to identify the magnitude and associated factors of epileptic patients at ambulato...

    Authors: Firomsa Bekele, Tadele Mamo and Ginenus Fekadu
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:71
    Content type: Research Published on:

  37. Novel therapeutic agents for SARS-CoV-2 have emerged over time, serving to reduce the severity of the disease, admission and mortality, especially among high-risk populations. Oral nirmatrelvir/ritonavir (Paxl...

    Authors: Chee Tao Chang, Su Yin Ong, Xin Jie Lim, Lan Sim Chew and Philip Rajan
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:70
    Content type: Commentary Published on:

  38. Competitive tenders on pharmaceuticals are one of the most effective cost-containment instruments in healthcare systems. Its effectiveness has been demonstrated, among other things, in markets for generic medi...

    Authors: Lars Holger Ehlers, Morten B. Jensen and Henrik Schack
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:69
    Content type: Research Published on:

  39. In India, due to a lack of population-level financial risk protection mechanisms, the expenditure on healthcare is primarily out-of-pocket in nature. Through Drug Price Control Orders (DPCOs), the Indian Gover...

    Authors: Sakthivel Selvaraj, Habib Hasan Farooqui, Aashna Mehta and Manu Raj Mathur
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:68
    Content type: Research Published on:

  40. There is lack of both resources and expertise explains the limited extent to which pharmacoeconomic evidence is used in formulary decision-making.

    Authors: Sabaa Saleh Al‑Hemyari, Dzul Azri Mohamed Noor and Faris El‑Dahiyat
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:67
    Content type: Research Published on:

  41. The effect of the COVID-19 pandemic on the mental health of healthcare workers is gaining attention globally. This study assessed the quality-of-working life (QoWL) and prevalence of, and risk factors for anxi...

    Authors: Sherishka Dhindayal, Marothi P. Letsoalo and Tanuja N. Gengiah
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:66
    Content type: Research Published on:

  42. Ethiopia is a country with high endemicity in Hepatitis B (HepB) virus infection. However, only 14% of healthcare workers (HCWs) are currently immunized via a non-mandatory strategy in the country. Hence, this...

    Authors: Dinksew Tewuhibo, Getahun Asmamaw and Wondim Ayenew
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:65
    Content type: Research Published on:

  43. Information about how newspapers portray antidiabetic medicines to readers is lacking. This study investigated the reporting on antidiabetic medicines in the most widely circulated newspapers published in the ...

    Authors: Nadia Farhanah Syafhan, Gaoyun Chen, Carole Parsons and James C. McElnay
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:64
    Content type: Research Published on:

  44. Upon the authorization of COVID-19 vaccines worldwide, national and international standards were developed to help integrate mass COVID-19 immunization campaigns into the healthcare network. The primary object...

    Authors: Abeer Zeitoun, Souheil Hallit, Maya Helali, Sirine Chehade, Carla Allam, Aya Ibrahim, Hani Dimassi and Rita Karam
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:63
    Content type: Research Published on:

  45. Medication errors have serious consequences for patients’ morbidity and mortality. The involvement of pharmacy professionals in the prescribing and dispensing procedure allowed the detection of a range of drug...

    Authors: Wudneh Simegn, Berhanemeskel Weldegerima, Mohammed Seid, Ayal Zewdie, Dawit Wondimsigegn, Chilot Abyu, Asmamaw Emagn Kasahun, Abdulwase Mohammed Seid, Gashaw Sisay and Yigizie Yeshaw
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:62
    Content type: Research Published on:

  46. Medication adherence, one of the most important aspects in the process of optimal medicines use, is unfortunately still a major challenge in modern healthcare, and further research is required into how adheren...

    Authors: Nadia Farhanah Syafhan, Rosemary Donnelly, Roy Harper, Janet Harding, Ciara Mulligan, Anita Hogg, Michael Scott, Glenda Fleming, Claire Scullin, Ahmed F. Hawwa, Gaoyun Chen, Carole Parsons and James C. McElnay
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:61
    Content type: Research Published on:

  47. Following the emergence of the global Coronavirus Disease-2019 (COVID-19) pandemic, alcohol-based hand sanitizers (ABHS) have been extensively used as one of the effective methods of preventing its transmissio...

    Authors: Tesfa Marew Wallelign, Muluken Nigatu Selam, Gebremariam Birhanu Wondie and Bruck Messele Habte
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:60
    Content type: Research Published on:

  48. To promote an acceptance rate of COVID-19 immunization among Thai children, concerns about parental vaccination hesitancy should be urgently studied. This study aimed to examine the parental COVID-19 vaccinati...

    Authors: Pantira Parinyarux, Kanokkarn Sunkonkit and Kitiyot Yotsombut
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:59
    Content type: Research Published on:

  49. Health supply chain systems are essential for effective and efficient healthcare system by ensuring availability of quality essential medicines and health supplies. While several interventions have been made t...

    Authors: Eric Lugada, Irene Ochola, Anthony Kirunda, Moses Sembatya, Sheila Mwebaze, Martin Olowo, Denis Okidi Ladwar and Henry Komakech
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:58
    Content type: Research Published on:

  50. Non-prescribed antibiotic use is an emerging risky practice around the globe. An inappropriate use involving nonprescription access is one cause of the rapid increase in antibiotic resistance. Children commonl...

    Authors: Dumessa Edessa, Nega Assefa, Yadeta Dessie, Fekede Asefa, Girmaye Dinsa and Lemessa Oljira
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:57
    Content type: Research Published on:
Submit manuscript

Follow

Annual Journal Metrics

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us